Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06837298 · ClinicalTrials.gov registry record · NA
The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery
A NA study of Muscle Damage and Muscle, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT06837298 is a NA study of Muscle Damage and Muscle that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 76 participants, above the 32-participant average among 6 other Muscle Damage trials with a reported enrollment target (138% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06837298, a NA study of Muscle Damage and Muscle, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
To investigate the effect of Vicia faba protein concentrate, a protein derived from Fava bean extract, on delayed onset muscle soreness (DOMS). Participants receive either 2.4g/day of PeptiStrong® supplement capsules or placebo capsules for 14 days until a strenuous exercise session. For the last 3 days, 2/3 of them stay on the same treatment and 1/3 of them switch from placebo to PeptiStrong®.
Conditions Studied
Interventions
- OTHER Placebo control capsules
- OTHER PeptiStrong® supplement capsules with same appearance as placebo capsules
- OTHER PeptiStrong® supplement capsules following muscle damaging exercise on Day 14
Study Locations (1)
Florida
- Gatorade Sports Science Institute at IMG Academy - Bradenton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06837298
The ClinicalTrials.gov registry entry for NCT06837298 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 32-participant average among 6 other Muscle Damage trials with a reported enrollment target (138% higher). The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Muscle Damage appearing as the primary indexed condition, and to 3 interventions - of which Placebo control capsules is the first listed.
NCT06837298 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06837298 about?
NCT06837298 is a clinical study titled "The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery". To investigate the effect of Vicia faba protein concentrate, a protein derived from Fava bean extract, on delayed onset muscle soreness (DOMS). Participants receive either 2.4g/day of PeptiStrong® supplement capsules or placebo capsules for 14 days until a strenuous exercise session. For the last 3 ...
What is the current status of trial NCT06837298?
This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2025-02-07. Estimated completion is 2025-09-30.
What conditions does trial NCT06837298 study?
This clinical trial studies the following conditions: Muscle Damage, Muscle.
What interventions are being tested in trial NCT06837298?
The interventions under investigation include: Placebo control capsules (OTHER), PeptiStrong® supplement capsules with same appearance as placebo capsules (OTHER), PeptiStrong® supplement capsules following muscle damaging exercise on Day 14 (OTHER).
Who is sponsoring clinical trial NCT06837298?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06837298 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Damage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Two Eccentric Protocols on Muscle Damage
RECRUITING · NA
-
Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise
RECRUITING · NA
-
HIFEM and Radiofrequency for Muscular System Function Improvement
ACTIVE NOT RECRUITING · NA
-
Protein and Recovery From Exercise-induced Muscle Damage
COMPLETED · NA
-
Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness
COMPLETED · NA
-
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.